Asymptomatic carriage of Entamoeba histolytica
Treat asymptomatic carriage of Entamoeba histolytica with a luminal agent to minimise transmission and the risk of developing invasive disease. UseKikuchi, 2013La Hoz, 2019:
paromomycin 500 mg (child: 10 mg/kg up to 500 mg) orally, 8-hourly for 7 days1. For dosage adjustment in adults with kidney impairment, see paromomycin dosage adjustment. paromomycin paromomycin paromomycin
1 Paromomycin is not registered for use in Australia but is available via the Special Access Scheme.Return